Charta Health is a technology company.
Charta Health has raised $30.0M across 2 funding rounds.
Charta Health has raised $30.0M in total across 2 funding rounds.
# Charta Health: AI-Powered Chart Review
Charta Health is an AI-enabled healthcare technology company that automates medical chart review to optimize revenue integrity and compliance for provider organizations. The platform conducts autonomous pre-bill reviews of patient charts, identifying missed coding opportunities, preventing claim denials, and ensuring regulatory compliance by integrating directly with existing electronic health record (EHR) systems[1][2].
The company serves large healthcare providers, health systems, and medical groups processing high volumes of patient encounters[4]. Its core value proposition centers on three outcomes: increasing revenue through better coding capture, reducing administrative burden on audit teams, and improving patient care quality through clinical insights[6]. Healthcare organizations across 43 states currently use Charta's software, with customers reporting up to 15.2% increases in relative value units (RVUs) per patient and 11% revenue uplift on average[3][6].
Charta Health was founded by Justin Liu (CEO and co-founder) and a co-founder who serves as CTO, both bringing deep expertise in AI infrastructure[2][5]. The company emerged from recognizing healthcare's fundamental operational inefficiencies—specifically the broken, legacy-dependent nature of chart review and billing workflows. Liu observed that "historically, the complexity and fragmentation of healthcare infrastructure made it nearly impossible to apply AI meaningfully at scale," but modern AI capabilities now enable meaningful intervention at the point of care[2].
The company achieved early traction through seed funding of $8.1 million earlier in 2025, followed by a $22 million Series A round led by Bain Capital Ventures with participation from SV Angel, South Park Commons, Madrona Venture Group, and Refract Ventures[2]. This funding trajectory reflects strong investor confidence in the market opportunity and the team's execution capability.
Charta Health distinguishes itself through several key advantages:
Charta Health operates at the intersection of two powerful healthcare trends: the shift toward AI-driven operational automation and the urgent need to address healthcare's administrative burden crisis. The company is riding the wave of recognition that healthcare's fragmented, legacy-dependent infrastructure—long resistant to technology disruption—can now be meaningfully improved through AI that works *with* existing systems rather than replacing them[5].
The timing is critical. Healthcare providers face simultaneous pressures: rising labor costs for manual auditing, increasing claim denial rates, complex multi-payer compliance requirements, and clinician burnout from administrative overhead. Charta's approach directly addresses these pain points by automating the most labor-intensive, error-prone processes while improving financial outcomes[3][6].
The company also represents a broader shift in healthcare AI from clinical decision support (the traditional focus) toward back-office operations and revenue cycle management—areas where AI can deliver immediate, measurable financial returns while freeing clinical staff to focus on patient care[3]. This positions Charta as part of the emerging "healthcare operations AI" category, distinct from clinical AI or diagnostic AI.
Charta Health is well-positioned to become the dominant platform for automated chart review and revenue cycle compliance. The company's $22 million Series A funding will accelerate engineering, go-to-market expansion, and enterprise integrations with both payers and providers—suggesting ambitions beyond individual provider adoption toward ecosystem-wide integration[2].
The natural evolution of Charta's influence will likely extend beyond chart review into broader compliance automation across the entire provider-payer relationship. As the company notes, chart review is "just the tip of the iceberg"—the platform could eventually serve as a "trust layer between the entire healthcare ecosystem of patients, providers and payers"[6].
Key trends shaping Charta's trajectory include: consolidation among healthcare providers (creating larger customers with greater integration needs), increasing regulatory scrutiny of billing practices (driving demand for audit-ready compliance), and the maturation of healthcare AI infrastructure (enabling more sophisticated, multi-use applications). The company's ability to expand beyond primary care and urgent care into complex specialties and health systems will determine whether it becomes a category leader or remains a valuable but niche solution.
Charta Health has raised $30.0M in total across 2 funding rounds.
Charta Health's investors include Abstract Ventures, Andreessen Horowitz, Bain Capital Ventures, Gradient Ventures.
Charta Health has raised $30.0M across 2 funding rounds. Most recently, it raised $22.0M Series A in July 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2025 | $22.0M Series A | Abstract Ventures, Andreessen Horowitz, Bain Capital Ventures, Gradient Ventures | |
| Feb 1, 2025 | $8.0M Seed | Abstract Ventures, Andreessen Horowitz, Bain Capital Ventures, Gradient Ventures |